Analysis of Solvency Ratios
Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Solvency Ratios (Summary)
Abiomed Inc., solvency ratios
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | |
| Debt to equity ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. | Abiomed Inc. debt to equity ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | |
| Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | Abiomed Inc. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | |
| Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | Abiomed Inc. debt to assets ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Abiomed Inc. financial leverage ratio decreased from 2020 to 2021 and from 2021 to 2022. |
| Solvency ratio | Description | The company |
|---|---|---|
| Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | Abiomed Inc. fixed charge coverage ratio deteriorated from 2020 to 2021 and from 2021 to 2022. |
Debt to Equity
Abiomed Inc., debt to equity calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Solvency Ratio | |||||||
| Debt to equity1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | |
| Benchmarks | |||||||
| Debt to Equity, Competitors2 | |||||||
| Abbott Laboratories | 0.46 | 0.50 | 0.57 | 0.58 | — | — | |
| Cigna Group | 0.69 | 0.71 | 0.65 | 0.83 | — | — | |
| CVS Health Corp. | 0.74 | 0.75 | 0.93 | 1.07 | — | — | |
| Elevance Health Inc. | 0.66 | 0.64 | 0.60 | 0.63 | — | — | |
| Humana Inc. | 0.75 | 0.80 | 0.51 | 0.49 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.46 | 0.51 | 0.49 | 0.51 | — | — | |
| UnitedHealth Group Inc. | 0.74 | 0.64 | 0.66 | 0.71 | — | — | |
| Debt to Equity, Sector | |||||||
| Health Care Equipment & Services | 0.63 | 0.63 | 0.65 | 0.72 | — | — | |
| Debt to Equity, Industry | |||||||
| Health Care | 0.72 | 0.78 | 0.90 | 0.91 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity
= 0 ÷ 1,503,326 = 0.00
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. |
Debt to Equity (including Operating Lease Liability)
Abiomed Inc., debt to equity (including operating lease liability) calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Operating lease liabilities in other current liabilities | 2,889) | 2,459) | 3,671) | —) | —) | —) | |
| Operating lease liabilities in other long-term liabilities | 6,618) | 3,657) | 8,549) | —) | —) | —) | |
| Total debt (including operating lease liability) | 9,507) | 6,116) | 12,220) | —) | —) | 16,338) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Solvency Ratio | |||||||
| Debt to equity (including operating lease liability)1 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.04 | |
| Benchmarks | |||||||
| Debt to Equity (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.49 | 0.54 | 0.61 | 0.61 | — | — | |
| Cigna Group | 0.70 | 0.73 | 0.67 | 0.84 | — | — | |
| CVS Health Corp. | 1.00 | 1.01 | 1.23 | 1.39 | — | — | |
| Elevance Health Inc. | 0.69 | 0.67 | 0.63 | 0.65 | — | — | |
| Humana Inc. | 0.79 | 0.84 | 0.54 | 0.53 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.48 | 0.53 | 0.51 | 0.51 | — | — | |
| UnitedHealth Group Inc. | 0.80 | 0.70 | 0.73 | 0.77 | — | — | |
| Debt to Equity (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.71 | 0.71 | 0.74 | 0.81 | — | — | |
| Debt to Equity (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.77 | 0.84 | 0.96 | 0.97 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Stockholders’ equity
= 9,507 ÷ 1,503,326 = 0.01
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. | Abiomed Inc. debt to equity ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Debt to Capital
Abiomed Inc., debt to capital calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Total capital | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 468,409) | |
| Solvency Ratio | |||||||
| Debt to capital1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| Benchmarks | |||||||
| Debt to Capital, Competitors2 | |||||||
| Abbott Laboratories | 0.31 | 0.34 | 0.36 | 0.37 | — | — | |
| Cigna Group | 0.41 | 0.42 | 0.40 | 0.45 | — | — | |
| CVS Health Corp. | 0.42 | 0.43 | 0.48 | 0.52 | — | — | |
| Elevance Health Inc. | 0.40 | 0.39 | 0.38 | 0.39 | — | — | |
| Humana Inc. | 0.43 | 0.44 | 0.34 | 0.33 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.31 | 0.34 | 0.33 | 0.34 | — | — | |
| UnitedHealth Group Inc. | 0.43 | 0.39 | 0.40 | 0.41 | — | — | |
| Debt to Capital, Sector | |||||||
| Health Care Equipment & Services | 0.39 | 0.39 | 0.39 | 0.42 | — | — | |
| Debt to Capital, Industry | |||||||
| Health Care | 0.42 | 0.44 | 0.47 | 0.48 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 0 ÷ 1,503,326 = 0.00
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. |
Debt to Capital (including Operating Lease Liability)
Abiomed Inc., debt to capital (including operating lease liability) calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Operating lease liabilities in other current liabilities | 2,889) | 2,459) | 3,671) | —) | —) | —) | |
| Operating lease liabilities in other long-term liabilities | 6,618) | 3,657) | 8,549) | —) | —) | —) | |
| Total debt (including operating lease liability) | 9,507) | 6,116) | 12,220) | —) | —) | 16,338) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Total capital (including operating lease liability) | 1,512,833) | 1,335,791) | 1,077,686) | 936,890) | 689,524) | 468,409) | |
| Solvency Ratio | |||||||
| Debt to capital (including operating lease liability)1 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.03 | |
| Benchmarks | |||||||
| Debt to Capital (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.33 | 0.35 | 0.38 | 0.38 | — | — | |
| Cigna Group | 0.41 | 0.42 | 0.40 | 0.46 | — | — | |
| CVS Health Corp. | 0.50 | 0.50 | 0.55 | 0.58 | — | — | |
| Elevance Health Inc. | 0.41 | 0.40 | 0.39 | 0.40 | — | — | |
| Humana Inc. | 0.44 | 0.46 | 0.35 | 0.34 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.32 | 0.35 | 0.34 | 0.34 | — | — | |
| UnitedHealth Group Inc. | 0.45 | 0.41 | 0.42 | 0.44 | — | — | |
| Debt to Capital (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.41 | 0.41 | 0.43 | 0.45 | — | — | |
| Debt to Capital (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.44 | 0.46 | 0.49 | 0.49 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 9,507 ÷ 1,512,833 = 0.01
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | Abiomed Inc. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Debt to Assets
Abiomed Inc., debt to assets calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Total assets | 1,673,393) | 1,494,359) | 1,216,462) | 1,054,346) | 786,375) | 550,414) | |
| Solvency Ratio | |||||||
| Debt to assets1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| Benchmarks | |||||||
| Debt to Assets, Competitors2 | |||||||
| Abbott Laboratories | 0.23 | 0.24 | 0.26 | 0.27 | — | — | |
| Cigna Group | 0.22 | 0.22 | 0.21 | 0.24 | — | — | |
| CVS Health Corp. | 0.23 | 0.24 | 0.28 | 0.31 | — | — | |
| Elevance Health Inc. | 0.23 | 0.24 | 0.23 | 0.26 | — | — | |
| Humana Inc. | 0.27 | 0.29 | 0.20 | 0.20 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.27 | 0.28 | 0.27 | 0.28 | — | — | |
| UnitedHealth Group Inc. | 0.23 | 0.22 | 0.22 | 0.23 | — | — | |
| Debt to Assets, Sector | |||||||
| Health Care Equipment & Services | 0.23 | 0.23 | 0.24 | 0.26 | — | — | |
| Debt to Assets, Industry | |||||||
| Health Care | 0.27 | 0.28 | 0.30 | 0.31 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to assets = Total debt ÷ Total assets
= 0 ÷ 1,673,393 = 0.00
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. |
Debt to Assets (including Operating Lease Liability)
Abiomed Inc., debt to assets (including operating lease liability) calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current portion of capital lease obligation | —) | —) | —) | —) | —) | 799) | |
| Capital lease obligation, net of current portion | —) | —) | —) | —) | —) | 15,539) | |
| Total debt | —) | —) | —) | —) | —) | 16,338) | |
| Operating lease liabilities in other current liabilities | 2,889) | 2,459) | 3,671) | —) | —) | —) | |
| Operating lease liabilities in other long-term liabilities | 6,618) | 3,657) | 8,549) | —) | —) | —) | |
| Total debt (including operating lease liability) | 9,507) | 6,116) | 12,220) | —) | —) | 16,338) | |
| Total assets | 1,673,393) | 1,494,359) | 1,216,462) | 1,054,346) | 786,375) | 550,414) | |
| Solvency Ratio | |||||||
| Debt to assets (including operating lease liability)1 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.03 | |
| Benchmarks | |||||||
| Debt to Assets (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.24 | 0.26 | 0.27 | 0.28 | — | — | |
| Cigna Group | 0.22 | 0.22 | 0.22 | 0.24 | — | — | |
| CVS Health Corp. | 0.31 | 0.33 | 0.37 | 0.40 | — | — | |
| Elevance Health Inc. | 0.24 | 0.25 | 0.24 | 0.27 | — | — | |
| Humana Inc. | 0.28 | 0.31 | 0.21 | 0.22 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.27 | 0.29 | 0.28 | 0.28 | — | — | |
| UnitedHealth Group Inc. | 0.25 | 0.24 | 0.24 | 0.26 | — | — | |
| Debt to Assets (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.26 | 0.27 | 0.27 | 0.29 | — | — | |
| Debt to Assets (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.29 | 0.30 | 0.32 | 0.33 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 9,507 ÷ 1,673,393 = 0.01
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | Abiomed Inc. debt to assets ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Financial Leverage
Abiomed Inc., financial leverage calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Total assets | 1,673,393) | 1,494,359) | 1,216,462) | 1,054,346) | 786,375) | 550,414) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Solvency Ratio | |||||||
| Financial leverage1 | 1.11 | 1.12 | 1.14 | 1.13 | 1.14 | 1.22 | |
| Benchmarks | |||||||
| Financial Leverage, Competitors2 | |||||||
| Abbott Laboratories | 2.03 | 2.10 | 2.21 | 2.18 | — | — | |
| Cigna Group | 3.21 | 3.29 | 3.09 | 3.44 | — | — | |
| CVS Health Corp. | 3.21 | 3.10 | 3.32 | 3.48 | — | — | |
| Elevance Health Inc. | 2.83 | 2.70 | 2.61 | 2.44 | — | — | |
| Humana Inc. | 2.81 | 2.76 | 2.55 | 2.42 | — | — | |
| Intuitive Surgical Inc. | 1.17 | 1.14 | 1.15 | 1.18 | — | — | |
| Medtronic PLC | 1.73 | 1.81 | 1.79 | 1.79 | — | — | |
| UnitedHealth Group Inc. | 3.16 | 2.96 | 3.01 | 3.02 | — | — | |
| Financial Leverage, Sector | |||||||
| Health Care Equipment & Services | 2.73 | 2.68 | 2.70 | 2.75 | — | — | |
| Financial Leverage, Industry | |||||||
| Health Care | 2.66 | 2.77 | 2.95 | 2.93 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity
= 1,673,393 ÷ 1,503,326 = 1.11
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Abiomed Inc. financial leverage ratio decreased from 2020 to 2021 and from 2021 to 2022. |
Interest Coverage
Abiomed Inc., interest coverage calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income | 136,505) | 225,525) | 203,009) | 259,016) | 112,170) | 52,116) | |
| Add: Income tax expense | 54,055) | 62,695) | 53,816) | 4,344) | 48,267) | 39,227) | |
| Add: Interest expense | —) | —) | —) | —) | 302) | 354) | |
| Earnings before interest and tax (EBIT) | 190,560) | 288,220) | 256,825) | 263,360) | 160,739) | 91,697) | |
| Solvency Ratio | |||||||
| Interest coverage1 | — | — | — | — | 532.25 | 259.03 | |
| Benchmarks | |||||||
| Interest Coverage, Competitors2 | |||||||
| Abbott Laboratories | 15.89 | 16.41 | 10.10 | 7.09 | — | — | |
| Cigna Group | 7.43 | 6.22 | 8.76 | 5.11 | — | — | |
| CVS Health Corp. | 3.46 | 5.16 | 4.36 | 3.96 | — | — | |
| Elevance Health Inc. | 10.13 | 10.93 | 8.96 | 9.02 | — | — | |
| Humana Inc. | 9.89 | 11.49 | 17.52 | 15.34 | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | — | |
| Medtronic PLC | 10.98 | 5.21 | 4.71 | 4.60 | — | — | |
| UnitedHealth Group Inc. | 13.59 | 14.44 | 13.47 | 11.55 | — | — | |
| Interest Coverage, Sector | |||||||
| Health Care Equipment & Services | 9.34 | 9.06 | 8.21 | 6.70 | — | — | |
| Interest Coverage, Industry | |||||||
| Health Care | 12.97 | 12.85 | 7.67 | 8.84 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Interest coverage = EBIT ÷ Interest expense
= 190,560 ÷ 0 = —
2 Click competitor name to see calculations.
Fixed Charge Coverage
Abiomed Inc., fixed charge coverage calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income | 136,505) | 225,525) | 203,009) | 259,016) | 112,170) | 52,116) | |
| Add: Income tax expense | 54,055) | 62,695) | 53,816) | 4,344) | 48,267) | 39,227) | |
| Add: Interest expense | —) | —) | —) | —) | 302) | 354) | |
| Earnings before interest and tax (EBIT) | 190,560) | 288,220) | 256,825) | 263,360) | 160,739) | 91,697) | |
| Add: Operating lease costs | 3,238) | 4,124) | 3,658) | —) | —) | —) | |
| Earnings before fixed charges and tax | 193,798) | 292,344) | 260,483) | 263,360) | 160,739) | 91,697) | |
| Interest expense | —) | —) | —) | —) | 302) | 354) | |
| Operating lease costs | 3,238) | 4,124) | 3,658) | —) | —) | —) | |
| Fixed charges | 3,238) | 4,124) | 3,658) | —) | 302) | 354) | |
| Solvency Ratio | |||||||
| Fixed charge coverage1 | 59.85 | 70.89 | 71.21 | — | 532.25 | 259.03 | |
| Benchmarks | |||||||
| Fixed Charge Coverage, Competitors2 | |||||||
| Abbott Laboratories | 10.10 | 10.21 | 6.68 | 5.14 | — | — | |
| Cigna Group | 6.87 | 5.61 | 7.84 | 4.67 | — | — | |
| CVS Health Corp. | 2.16 | 3.03 | 2.75 | 2.56 | — | — | |
| Elevance Health Inc. | 8.82 | 8.48 | 6.10 | 7.34 | — | — | |
| Humana Inc. | 7.10 | 8.05 | 12.02 | 9.76 | — | — | |
| Intuitive Surgical Inc. | 63.52 | 93.66 | 58.48 | 79.65 | — | — | |
| Medtronic PLC | 7.79 | 4.31 | 3.98 | 3.97 | — | — | |
| UnitedHealth Group Inc. | 8.77 | 8.80 | 8.51 | 7.65 | — | — | |
| Fixed Charge Coverage, Sector | |||||||
| Health Care Equipment & Services | 6.16 | 5.95 | 5.52 | 4.75 | — | — | |
| Fixed Charge Coverage, Industry | |||||||
| Health Care | 9.19 | 9.09 | 5.67 | 6.58 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 193,798 ÷ 3,238 = 59.85
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | Abiomed Inc. fixed charge coverage ratio deteriorated from 2020 to 2021 and from 2021 to 2022. |